Delivery Order SPE2DB22D3016-SPE2DB25FALT6

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,547.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a prescription medication, and has an ultimate completion date of July 3, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,094.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a prescription medication, with a completion date of January 7, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,097.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a period of performance through February 5, 2025. This contract award is not associated with a set-aside designation....
This federal contract award, valued at $2,541.43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559684887 - DEXMETHYLPHENIDATE ER CAPS 10MG, a prescription medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $2,467.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566746759 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, with a completion date of December 18, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. No set-aside was used for this award. Amerisourcebergen holds significant Indefinite Delivery...
This federal contract award, valued at $3,014.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,373,469 units of DEXMETHYLPHENIDATE ER 20 MG CP, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,206.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567105441 - DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product, with a period of performance through January 31, 2025. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The U.S. Defense Logistics Agency (DLA) awarded a $1,600.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565843238 - DEXMETHYLPHENIDATE ER 10 MG CP 100S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,537.35 delivery order contract is for the provision of 4,566,583,639 units of the drug DEXMETHYLPHENIDATE ER 20 MG CP, with a performance period through December 3, 2024. The contract is a firm fixed-price award and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.40 firm fixed-price delivery order is for the supply of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a generic prescription medication. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FALT6
    Delivery Order

This federal contract award, valued at $2,038.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a pharmaceutical product, with a period of performance through January 31, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/4/25, 12:52 AM